FDA Drug · D-0071-2026

Cerebrolysin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Class II · Ongoing

Lack of Assurance of Sterility

Affected lots / codes — check yours against thisAll lots within expiry.

Recalling firm: GenoGenix LLC, Boca Raton, FL
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: —
Distribution: US Nationwide.
Recall initiated: July 30, 2025
Classified: October 21, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0071-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →